BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18257400)

  • 1. Capecitabine-related cardiotoxicity: recognition and management.
    Saif MW; Tomita M; Ledbetter L; Diasio RB
    J Support Oncol; 2008 Jan; 6(1):41-8. PubMed ID: 18257400
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coronary insufficiency after an oral intake of capecitabine].
    Desramé J; Bronstein JA; Thiolet C; Bredin C; Ceccaldi B; Vergeau B; Farret O
    Gastroenterol Clin Biol; 2001; 25(8-9):829-30. PubMed ID: 11598548
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiotoxicity induced by 5-fluorouracil or capecitabine].
    Jensen SA; Baeksgaard L; Petersen LN; Reiter L; Sørensen JB
    Ugeskr Laeger; 2010 Jan; 172(1):48-51. PubMed ID: 20056096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation of actinic keratoses with capecitabine therapy for colon cancer.
    Serrão VV; Feio AB
    Eur J Dermatol; 2008; 18(2):200. PubMed ID: 18424393
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac toxicity associated with capecitabine therapy.
    Saif MW; Quinn MG; Thomas RR; Ernst A; Grem JL
    Acta Oncol; 2003; 42(4):342-4. PubMed ID: 12899507
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute coronary syndrome induced by capecitabine therapy.
    Wijesinghe N; Thompson PI; McAlister H
    Heart Lung Circ; 2006 Oct; 15(5):337-9. PubMed ID: 16697705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hypertriglyceridaemia associated with the use of capecitabine.
    Polinder-Bos HA; Kok EE; van de Wiel A; Spiering W; Wielders JP; Bloemendal HJ
    Neth J Med; 2012 Mar; 70(2):104. PubMed ID: 22418760
    [No Abstract]   [Full Text] [Related]  

  • 8. Standard-dose tegafur combined with uracil is not safe treatment after severe toxicity from 5-fluorouracil or capecitabine.
    Deenen MJ; Terpstra WE; Cats A; Boot H; Schellens JH
    Ann Intern Med; 2010 Dec; 153(11):767-8. PubMed ID: 21135311
    [No Abstract]   [Full Text] [Related]  

  • 9. Capecitabine induced cardiotoxicity: a case report and review of literature.
    Tunio MA; Hashmi A; Shoaib M
    Pak J Pharm Sci; 2012 Jan; 25(1):277-81. PubMed ID: 22186341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capecitabine cardiotoxicity--case reports and literature review.
    Manojlovic N; Babic D; Stojanovic S; Filipovic I; Radoje D
    Hepatogastroenterology; 2008; 55(85):1249-56. PubMed ID: 18795667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.
    Jensen SA; Sørensen JB
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
    Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530
    [No Abstract]   [Full Text] [Related]  

  • 13. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
    Dalmau J; Roé E; Puig L; Alomar A
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
    [No Abstract]   [Full Text] [Related]  

  • 14. Capecitabine cardiac toxicity presenting as effort angina: a case report.
    Lestuzzi C; Crivellari D; Rigo F; Viel E; Meneguzzo N
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):700-3. PubMed ID: 20093950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient.
    Aksoy S; Karaca B; Dinçer M; Yalçin S
    Ann Pharmacother; 2005 Mar; 39(3):573-4. PubMed ID: 15701780
    [No Abstract]   [Full Text] [Related]  

  • 16. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
    Shaib W; Lee V; Saif MW
    In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capecitabine-induced acute myeloid leukaemia.
    Tansley S; Gibbons S
    N Z Med J; 2009 May; 122(1294):118-9. PubMed ID: 19465957
    [No Abstract]   [Full Text] [Related]  

  • 18. Capecitabine induced inflammation of actinic keratoses.
    Krathen M; Treat J; James WD
    Dermatol Online J; 2007 Oct; 13(4):13. PubMed ID: 18319010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
    Ghosal N; Misra V
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
    [No Abstract]   [Full Text] [Related]  

  • 20. Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer.
    Hague JS; Ilchyshyn A
    Clin Exp Dermatol; 2007 Jan; 32(1):102-3. PubMed ID: 16879449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.